157 related articles for article (PubMed ID: 36591262)
1. Delineating the molecular landscape of different histopathological growth patterns in colorectal cancer liver metastases.
Hu M; Chen Z; Hu D; Xi S; Wang D; Zhang X; Fong WP; Wen L; Cai Y; Yuan Y; Li B; Wu X; Lu Z; Chen G; Li L; Ding P; Pan Z; Wan D; Du Z; Chen M; Li Y
Front Immunol; 2022; 13():1045329. PubMed ID: 36591262
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications and mechanism of histopathological growth pattern in colorectal cancer liver metastases.
Kong BT; Fan QS; Wang XM; Zhang Q; Zhang GL
World J Gastroenterol; 2022 Jul; 28(26):3101-3115. PubMed ID: 36051338
[TBL] [Abstract][Full Text] [Related]
3. Replacement and desmoplastic histopathological growth patterns in cutaneous melanoma liver metastases: frequency, characteristics, and robust prognostic value.
Barnhill R; van Dam PJ; Vermeulen P; Champenois G; Nicolas A; Rawson RV; Wilmott JS; Thompson JF; Long GV; Cassoux N; Roman-Roman S; Busam KJ; Scolyer RA; Lazar AJ; Lugassy C
J Pathol Clin Res; 2020 Jul; 6(3):195-206. PubMed ID: 32304183
[TBL] [Abstract][Full Text] [Related]
4. Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases.
Galjart B; Nierop PMH; van der Stok EP; van den Braak RRJC; Höppener DJ; Daelemans S; Dirix LY; Verhoef C; Vermeulen PB; Grünhagen DJ
Angiogenesis; 2019 May; 22(2):355-368. PubMed ID: 30637550
[TBL] [Abstract][Full Text] [Related]
5. Histopathological growth patterns of resected non-colorectal, non-neuroendocrine liver metastases: a retrospective multicenter study.
Meyer Y; Bohlok A; Höppener D; Galjart B; Doukas M; Grünhagen DJ; Labar A; Lucidi V; Vermeulen PB; Verhoef C; Donckier V
Clin Exp Metastasis; 2022 Jun; 39(3):433-442. PubMed ID: 35124739
[TBL] [Abstract][Full Text] [Related]
6. International consensus guidelines for scoring the histopathological growth patterns of liver metastasis.
van Dam PJ; van der Stok EP; Teuwen LA; Van den Eynden GG; Illemann M; Frentzas S; Majeed AW; Eefsen RL; Coebergh van den Braak RRJ; Lazaris A; Fernandez MC; Galjart B; Laerum OD; Rayes R; Grünhagen DJ; Van de Paer M; Sucaet Y; Mudhar HS; Schvimer M; Nyström H; Kockx M; Bird NC; Vidal-Vanaclocha F; Metrakos P; Simoneau E; Verhoef C; Dirix LY; Van Laere S; Gao ZH; Brodt P; Reynolds AR; Vermeulen PB
Br J Cancer; 2017 Nov; 117(10):1427-1441. PubMed ID: 28982110
[TBL] [Abstract][Full Text] [Related]
7. Histopathological growth patterns of neuroendocrine tumor liver metastases.
Meyer Y; Bohlok A; Olthof P; Donckier V; Doukas M; Lucidi V; Vermeulen P; Grünhagen D; Verhoef C
Clin Exp Metastasis; 2023 Jun; 40(3):227-234. PubMed ID: 37183203
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of adaptive immune features in MMR-proficient colorectal liver metastases classified by histopathological growth patterns.
Messaoudi N; Henault D; Stephen D; Cousineau I; Simoneau E; Rong Z; Létourneau R; Plasse M; Dagenais M; Roy A; Lapointe R; Vandenbroucke-Menu F; Kunda R; Ysebaert D; Soucy G; Stagg J; Vermeulen P; Turcotte S
Br J Cancer; 2022 May; 126(9):1329-1338. PubMed ID: 34980880
[TBL] [Abstract][Full Text] [Related]
9. The relationship between primary colorectal cancer histology and the histopathological growth patterns of corresponding liver metastases.
Höppener DJ; Stook JPL; Galjart B; Nierop PMH; Nagtegaal ID; Vermeulen PB; Grünhagen DJ; Verhoef C; Doukas M;
BMC Cancer; 2022 Aug; 22(1):911. PubMed ID: 35996090
[TBL] [Abstract][Full Text] [Related]
10. Preoperative systemic chemotherapy alters the histopathological growth patterns of colorectal liver metastases.
Nierop PM; Höppener DJ; Buisman FE; van der Stok EP; Galjart B; Balachandran VP; Jarnagin WR; Kingham TP; Shia J; Mauer M; Nordlinger B; Julié C; Groot Koerkamp B; Doukas M; Vermeulen PB; Grünhagen DJ; D'Angelica MI; Verhoef C
J Pathol Clin Res; 2022 Jan; 8(1):48-64. PubMed ID: 34480530
[TBL] [Abstract][Full Text] [Related]
11. Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights.
Latacz E; Höppener D; Bohlok A; Leduc S; Tabariès S; Fernández Moro C; Lugassy C; Nyström H; Bozóky B; Floris G; Geyer N; Brodt P; Llado L; Van Mileghem L; De Schepper M; Majeed AW; Lazaris A; Dirix P; Zhang Q; Petrillo SK; Vankerckhove S; Joye I; Meyer Y; Gregorieff A; Roig NR; Vidal-Vanaclocha F; Denis L; Oliveira RC; Metrakos P; Grünhagen DJ; Nagtegaal ID; Mollevi DG; Jarnagin WR; D'Angelica MI; Reynolds AR; Doukas M; Desmedt C; Dirix L; Donckier V; Siegel PM; Barnhill R; Gerling M; Verhoef C; Vermeulen PB
Br J Cancer; 2022 Oct; 127(6):988-1013. PubMed ID: 35650276
[TBL] [Abstract][Full Text] [Related]
12. Can medical imaging identify the histopathological growth patterns of liver metastases?
Latacz E; van Dam PJ; Vanhove C; Llado L; Descamps B; Ruiz N; Joye I; Grünhagen D; Van Laere S; Dirix P; Mollevi DG; Verhoef C; Dirix L; Vermeulen P
Semin Cancer Biol; 2021 Jun; 71():33-41. PubMed ID: 32735852
[TBL] [Abstract][Full Text] [Related]
13. Tissue inhibitor of matrix metalloproteinase-1 expression in colorectal cancer liver metastases is associated with vascular structures.
Illemann M; Eefsen RH; Bird NC; Majeed A; Osterlind K; Laerum OD; Alpízar-Alpízar W; Lund IK; Høyer-Hansen G
Mol Carcinog; 2016 Feb; 55(2):193-208. PubMed ID: 25594187
[TBL] [Abstract][Full Text] [Related]
14. Histologic features and genomic alterations of primary colorectal adenocarcinoma predict growth patterns of liver metastasis.
Wu JB; Sarmiento AL; Fiset PO; Lazaris A; Metrakos P; Petrillo S; Gao ZH
World J Gastroenterol; 2019 Jul; 25(26):3408-3425. PubMed ID: 31341365
[TBL] [Abstract][Full Text] [Related]
15. Histopathological growth patterns as a candidate biomarker for immunomodulatory therapy.
van Dam PJ; Daelemans S; Ross E; Waumans Y; Van Laere S; Latacz E; Van Steen R; De Pooter C; Kockx M; Dirix L; Vermeulen PB
Semin Cancer Biol; 2018 Oct; 52(Pt 2):86-93. PubMed ID: 29355613
[TBL] [Abstract][Full Text] [Related]
16. Histopathological growth patterns as biomarker for adjuvant systemic chemotherapy in patients with resected colorectal liver metastases.
Buisman FE; van der Stok EP; Galjart B; Vermeulen PB; Balachandran VP; Coebergh van den Braak RRJ; Creasy JM; Höppener DJ; Jarnagin WR; Kingham TP; Nierop PMH; Sadot E; Shia J; Groot Koerkamp B; Grünhagen DJ; D'Angelica M; Verhoef C
Clin Exp Metastasis; 2020 Oct; 37(5):593-605. PubMed ID: 32691187
[TBL] [Abstract][Full Text] [Related]
17. Histological growth patterns of colorectal cancer liver metastases: a strong prognostic marker associated with invasive patterns of the primary tumor and p53 alteration.
Abe H; Yasunaga Y; Yamazawa S; Nakai Y; Gonoi W; Nishioka Y; Murono K; Sasaki K; Arita J; Kawai K; Nozawa H; Hasegawa K; Ishihara S; Ushiku T
Hum Pathol; 2022 May; 123():74-83. PubMed ID: 35247436
[TBL] [Abstract][Full Text] [Related]
18. Neutrophils expressing lysyl oxidase-like 4 protein are present in colorectal cancer liver metastases resistant to anti-angiogenic therapy.
Palmieri V; Lazaris A; Mayer TZ; Petrillo SK; Alamri H; Rada M; Jarrouj G; Park WY; Gao ZH; McDonald PP; Metrakos P
J Pathol; 2020 Jun; 251(2):213-223. PubMed ID: 32297656
[TBL] [Abstract][Full Text] [Related]
19. Histopathological growth pattern of liver metastases as an independent marker of metastatic behavior in different primary cancers.
Bohlok A; Richard F; Lucidi V; Asmar AE; Demetter P; Craciun L; Larsimont D; Hendlisz A; Van Laethem JL; Dirix L; Desmedt C; Vermeulen P; Donckier V
Front Oncol; 2023; 13():1260880. PubMed ID: 37965465
[TBL] [Abstract][Full Text] [Related]
20. Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution.
Fleischer JR; Schmitt AM; Haas G; Xu X; Zeisberg EM; Bohnenberger H; Küffer S; Teuwen LA; Karras PJ; Beißbarth T; Bleckmann A; Planque M; Fendt SM; Vermeulen P; Ghadimi M; Kalucka J; De Oliveira T; Conradi LC
Mol Cancer; 2023 Jan; 22(1):17. PubMed ID: 36691028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
